Detalles de la búsqueda
1.
Therapeutic efficacy and infectious complications of CD19-targeted chimeric antigen receptor-modified T cell immunotherapy.
Anticancer Drugs
; 34(4): 551-557, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36728516
2.
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Am J Hematol
; 98(10): 1588-1597, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470365
3.
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Am J Hematol
; 98(10): 1579-1587, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37466271
4.
The impact of second-donor lymphocyte infusion on secondary graft failure after allogeneic hematopoietic stem cell transplantation through activation of Foxp3 and regulatory T cells.
Cytotherapy
; 24(9): 923-930, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35365413
5.
Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.
Age Ageing
; 51(1)2022 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34673897
6.
Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age.
Platelets
; 32(5): 633-641, 2021 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32614630
7.
Pomalidomide improves the effectiveness of CAR-T treatment in the relapsed and refractory multiple myeloma or B-cell leukemia/lymphoma with extramedullary disease.
Blood Sci
; 6(2): e00184, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38433987
8.
Analysis and clinical characteristics of acute myeloid leukemia developing with prior or concurrent tumors in non cyto- or radiotherapy exposure patients in a single center.
Hematology
; 28(1): 2230738, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37427790
9.
[Comparison of Plerixafor or Cyclophosphamide Combined with G-CSF in Mobilization of Peripheral Blood Stem Cells in Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(5): 1403-1409, 2023 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-37846691
10.
[Clinical Characteristics and Nomogram Model of Nosocomial Infection in Patients with Newly Diagnosed Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(2): 420-428, 2023 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-37096514
11.
[Analysis of Pathogenic Bacterial Spectrum, Drug Resistance and Risk Factors for Mortality of Bloodstream Infection in Patients with Hematologic Diseases].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(5): 1556-1562, 2023 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-37846716
12.
[Clinical Characteristics and Risk Factors for 30-Day Mortality in Patients with Hematologic Diseases Infected by Carbapenem-Resistant Organisms].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(4): 1199-1204, 2023 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-37551498
13.
[Efficacy of Activated Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 31(5): 1509-1515, 2023.
Artículo
en Zh
| MEDLINE | ID: mdl-37846709
14.
Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China.
Front Oncol
; 13: 1028571, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37152063
15.
A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study.
Sci Bull (Beijing)
; 68(18): 2106-2114, 2023 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37599175
16.
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.
Lancet Reg Health West Pac
; 34: 100720, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37283978
17.
Effect of Donor Lymphocyte Infusion From Two Types of Donors on Mixed Chimerism With Secondary Graft Failure After Allogeneic Hematopoietic Stem Cell Transplantation.
Transplant Cell Ther
; 28(3): 152.e1-152.e7, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973501
18.
Carfilzomib inhibits the proliferation and apoptosis of multiple myeloma cells by inhibiting STAT1/COX-2/iNOS signaling pathway.
Transl Cancer Res
; 11(1): 206-216, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35261897
19.
Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter study.
Blood Adv
; 6(14): 4320-4329, 2022 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35679462
20.
[The Prognostic Value of Early Relapse after Autologous Hematopoietic Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 29(2): 535-539, 2021 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-33812427